Find A Doctor Find A Service Make An Appointment Talk To A Doctor

RESEARCHbanner
increase text size decrease text size printer friendly



  • Brain Cancer

  • Brain Cancer

    Title(s):
    NRG-BN001. Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Brain Cancer

    Title(s):
    CTSU A071102. A Phase II/III Randomized Trial Of Veliparib Or Placebo In Combination With Adjuvant Temozolomide In Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Brain Cancer

    Title(s):
    CTSU A221101. A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (NuvigilĀ®) to Reduce Cancer-Related Fatigue in Patients with High Grade Glioma

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Brain Cancer

    Title(s):
    NRG-CC001. A Randomized, Phase III Trial Of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Brain Cancer

    Title(s):
    NRG-CC003. Randomized phase II/III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small cell lung cancer

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 33-344-6348

  • Brain Cancer

    Title(s):
    CTSU A221208. Randomized Phase II Study: Corticosteroids + Bevacizumab Vs. Corticosteroids + Placebo (Best) For Radionecrosis After Radiosurgery For Brain Metastases

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  •  




    Cleveland Clinic Akron General • 1 Akron General Avenue • Akron, OH 44307 • 330.344.6000 • 1.800.221.4601    © 2016 Cleveland Clinic Akron General



    This website is certified by Health On the Net Foundation. Click to verify.

      This site complies with the HONcode standard for trustworthy health information: verify here.